Abstract Objective To summarize the clinical manifestations and genetic characteristics of creatine deficiency syndrome (CDS) caused by GAMT gene mutations. Methods A retrospective analysis was conducted on the clinical and genetic data of two children diagnosed with GAMT deficiency-type CDS at the Children's Medical Center of Xiangya Hospital, Central South University, from December 2020 to December 2024. Results The two patients presented with symptoms in infancy, and both had compound heterozygous mutations in the GAMT gene. Case 1 exhibited seizures and intellectual disability, while Case 2 had intellectual disability and attention-deficit hyperactivity disorder. Magnetic resonance spectroscopy of cranial MRI in both patients indicated reduced creatine peaks. After creatine treatment, seizures in Case 1 were controlled, but both patients continued to experience intellectual disabilities and behavioral issues. As of December 2024, a total of 21 cases have been reported in China (including this study), and 115 cases have been reported abroad. All patients exhibited developmental delay or intellectual disabilities, with 66.9% (91/136) experiencing seizures, 33.8% (46/136) presenting with motor disorders, and 36.8% (50/136) having behavioral problems. Seventy-five percent (102/136) of patients received creatine treatment, leading to significant improvements in seizures and motor disorders, although cognitive improvement was not substantial. Conclusions GAMT deficiency-type CDS is rare and presents with nonspecific clinical features. Timely diagnosis facilitates targeted treatment, which can partially improve prognosis.
ZHAO Ting-Ting,PAN Zou,ZHONG Jian-Min et al. Two cases of creatine deficiency syndrome caused by GAMT gene mutations and literature review[J]. CJCP, 2025, 27(3): 340-346.
ZHAO Ting-Ting,PAN Zou,ZHONG Jian-Min et al. Two cases of creatine deficiency syndrome caused by GAMT gene mutations and literature review[J]. CJCP, 2025, 27(3): 340-346.
St?ckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism[J]. Pediatr Res, 1994, 36(3): 409-413. PMID: 7808840. DOI: 10.1203/00006450-199409000-00023.
Rossi L, Nardecchia F, Pierigè F, et al. Intellectual disability and brain creatine deficit: phenotyping of the genetic mouse model for GAMT deficiency[J]. Genes (Basel), 2021, 12(8): 1201. PMID: 34440375. PMCID: PMC8391262. DOI: 10.3390/genes12081201.
3 Mercimek-Andrews S, Salomons GS. Creatine Deficiency Disorders[M]//Adam MP, Feldman J, Mirzaa GM, et al. GeneReviews? [Internet]. Seattle (WA): University of Washington, Seattle, 1993.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMID: 25741868. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30.
Uemura T, Ito S, Ohta Y, et al. Abnormal N-glycosylation of a novel missense creatine transporter mutant, G561R, associated with cerebral creatine deficiency syndromes alters transporter activity and localization[J]. Biol Pharm Bull, 2017, 40(1): 49-55. PMID: 28049948. DOI: 10.1248/bpb.b16-00582.
Clark JF, Cecil KM. Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes[J]. Pediatr Res, 2015, 77(3): 398-405. PMID: 25521922. DOI: 10.1038/pr.2014.203.
Y?ld?z Y, Ard??l? D, G??men R, et al. Electro-clinical features and long-term outcomes in guanidinoacetate methyltransferase (GAMT) deficiency[J]. Eur J Paediatr Neurol, 2024, 49: 66-72. PMID: 38394710. DOI: 10.1016/j.ejpn.2024.02.006.
Mikati AG, Abu Gheida I, Shamseddine A, et al. Epileptic and electroencephalographic manifestations of guanidinoacetate-methyltransferase deficiency[J]. Epileptic Disord, 2013, 15(4): 407-416. PMID: 24165373. DOI: 10.1684/epd.2013.0609.
Fernandes-Pires G, Braissant O. Current and potential new treatment strategies for creatine deficiency syndromes[J]. Mol Genet Metab, 2022, 135(1): 15-26. PMID: 34972654. DOI: 10.1016/j.ymgme.2021.12.005.
12 Akiyama T, Osaka H, Shimbo H, et al. A Japanese adult case of guanidinoacetate methyltransferase deficiency[M]//Zschocke J, Gibson KM, Brown G, et al.Cham: Springer International Publishing, 2014: 65-69.
